Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 09-2018 | |
| Sales | 129,252 | 10,198 | 0 |
| Cost of Goods | 86,338 | 6,231 | N/A |
| Gross Profit | 42,914 | 3,967 | N/A |
| Operating Expenses | 35,976 | 11,994 | 214 |
| Operating Income | 6,938 | -8,027 | -214 |
| Interest Expense | 672 | 364 | N/A |
| Other Income | 486 | -75 | 2 |
| Pre-tax Income | 6,752 | -8,466 | -211 |
| Income Tax | 5,621 | N/A | N/A |
| Net Income Continuous | 1,131 | -8,466 | -211 |
| Minority Interests | 514 | 80 | N/A |
| Net Income | $1,645 | $-8,386 | $-211 |
| EPS Basic Total Ops | 0.01 | -0.12 | -0.33 |
| EPS Basic Continuous Ops | 0.01 | -0.12 | -0.33 |
| EPS Diluted Total Ops | 0.01 | -0.12 | -0.33 |
| EPS Diluted Continuous Ops | 0.01 | -0.12 | -0.33 |
| EBITDA(a) | $9,955 | $-7,120 | $-214 |